Hiraide, Sakura
Komine, Keigo
Sato, Yuko
Ouchi, Kota
Imai, Hiroo
Saijo, Ken
Takahashi, Masahiro
Takahashi, Shin
Shirota, Hidekazu
Takahashi, Masanobu
Ishioka, Chikashi
Article History
Received: 25 July 2019
Accepted: 29 November 2019
First Online: 10 December 2019
Compliance with ethical standards
:
: Chikashi Ishioka received research funding from the Tokyo Cooperative Oncology Group. Chikashi Ishioka received contributions from Chugai Pharmaceutical, Asahi Kasei Pharma Corporation, Ono pharmaceutical, MSD, Pfizer, AstraZeneca, Bristol-Myers Squibb, Janssen Pharmaceutical, Taiho Pharmaceutical, Eisai Pharmaceutical, Daiichi Sankyo Company, Limited, and Takeda Pharmaceutical. Shin Takahashi received lecture fee from Asahi Kasei Pharma Corporation. Masahiro Takahashi has received research funding from Ono Pharmaceutical Company. Masanobu Takahashi has received research funding from Ono Pharmaceutical Company. Chikashi Ishioka is a representative of Tohoku Clinical Oncology Research and Education Society, a specified non-profit corporation.